|
Roldan V, Lecumberri R, Muñoz-Torrero JF, Vicente V, Rocha E, Brenner B, Monreal M; RIETE Investigators. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res. 2009 Jun;124(2):174-7. doi: 10.1016/j.thromres.2008.11.003. Epub 2008 Dec 20. PubMed PMID: 19101711.
AÑO: 2009; IF: 2.406
|
19101711
|
Navarro-Núñez L, Roldán V, Lozano ML, Rivera J, Marin F, Vicente V, Martínez C. TUBB1 Q43P polymorphism does not protect against acute coronary syndrome and premature myocardial infarction. Thromb Haemost. 2008 Dec;100(6):1211-3. PubMed PMID: 19132255.
AÑO: 2008; IF: 3.803
|
|
Navarro-Núñez L, Castillo J, Lozano ML, Martínez C, Benavente-García O, Vicente V, Rivera J. Thromboxane A2 receptor antagonism by flavonoids: structure-activity relationships. J Agric Food Chem. 2009 Feb 25;57(4):1589-94. doi: 10.1021/jf803041k. PubMed PMID: 19182941.
AÑO: 2009; IF: 2.469
|
|
Antón AI, Teruel R, Corral J, Miñano A, Martínez-Martínez I, Ordóñez A, Vicente V, Sánchez-Vega B. Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels. Haematologica. 2009 Apr;94(4):589-92. doi: 10.3324/haematol.2008.000604. Epub 2009 Feb 19. PubMed PMID: 19229049; PubMed Central PMCID: PMC2663624.
AÑO: 2009; IF: 6.416
|
|
Pérez-Andreu V, Roldán V, Antón AI, García-Barberá N, Corral J, Vicente V, González-Conejero R. Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy. Blood. 2009 May 14;113(20):4977-9. doi: 10.1182/blood-2008-09-176222. Epub 2009 Mar 6. PubMed PMID: 19270263.
AÑO: 2009; IF: 10.555
|